Mortality After Acute Coronary Syndrome in Human Immunodeficiency Virus Infection with Optimal Adherence: A Nationwide Study
- PMID: 38014728
- PMCID: PMC10771943
- DOI: 10.3947/ic.2023.0050
Mortality After Acute Coronary Syndrome in Human Immunodeficiency Virus Infection with Optimal Adherence: A Nationwide Study
Abstract
Background: There have been few studies on the outcome of acute coronary syndrome (ACS) in human immunodeficiency virus (HIV) infection in the era when antiretroviral therapy (ART) is generalized and most of them have achieved viral suppression. Using claims data, we aimed to assess the mortality after atherosclerotic cardiovascular events in people with HIV (PWH) who maintain optimal adherence to ART.
Materials and methods: We used claims data from the National Health Insurance of the Korea to confirm newly diagnosed PWH from 2009 to 2019, and measured ART adherence. ACS and mortality were confirmed in PWH who showed optimal adherence to ART.
Results: Among 7,100 PWH with optimal adherence and during 27,387 person-year of follow-up duration, ACS was confirmed in 140 (2.0%) cases, which was 1.3 times greater than statistics of the Korean general population (511.0 vs. 383.1 per 100,000). Acquired immunodeficiency syndrome, hypertension, dyslipidemia, and diabetes mellitus were associated with the development of ACS in PWH with optimal adherence. Mortality was confirmed in 10 cases, which is 7.1% overall and 2.9% when limited to myocardial infarction. It was comparable with the mortality rate of the Korean general population after myocardial infarction (8.9%).
Conclusion: ACS prevalence was higher in PWH even when optimal adherence was maintained. However, mortality after ACS was comparable to that in the HIV-negative population.
Keywords: Anti-retroviral agents; Epidemiology; HIV; Insurance claim review; Myocardial infarction.
Copyright © 2023 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS.
Conflict of interest statement
No conflict of interest.
Similar articles
-
The Medication Possession Ratio as a Predictor of Longitudinal HIV-1 Viral Suppression.Ann Pharmacother. 2023 Nov;57(11):1264-1272. doi: 10.1177/10600280231156624. Epub 2023 Mar 22. Ann Pharmacother. 2023. PMID: 36946586
-
Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.J Manag Care Pharm. 2011 Apr;17(3):213-23. doi: 10.18553/jmcp.2011.17.3.213. J Manag Care Pharm. 2011. PMID: 21434698 Free PMC article.
-
Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression.Open Forum Infect Dis. 2023 May 3;10(5):ofad230. doi: 10.1093/ofid/ofad230. eCollection 2023 May. Open Forum Infect Dis. 2023. PMID: 37213424 Free PMC article.
-
Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy.Eur Heart J. 2012 Apr;33(7):875-80. doi: 10.1093/eurheartj/ehr456. Epub 2011 Dec 20. Eur Heart J. 2012. PMID: 22187508 Free PMC article. Review.
-
Antiretrovirals for People with HIV on Dialysis.AIDS Patient Care STDS. 2022 Mar;36(3):86-96. doi: 10.1089/apc.2021.0173. AIDS Patient Care STDS. 2022. PMID: 35289690 Review.
Cited by
-
The epidemiology of HIV/AIDS and the use of antiretroviral therapy in Korea: a narrative review.Ewha Med J. 2024 Jul;47(3):e36. doi: 10.12771/emj.2024.e36. Epub 2024 Jul 31. Ewha Med J. 2024. PMID: 40703463 Free PMC article. Review.
-
Antiretroviral Therapy during Long-term Surgical Care: 'Exploring Difficult Cases in HIV Clinics' of the Korean Society for AIDS Conference in 2023.Infect Chemother. 2024 Sep;56(3):287-299. doi: 10.3947/ic.2024.0052. Epub 2024 Aug 1. Infect Chemother. 2024. PMID: 39231503 Free PMC article. Review.
References
-
- Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, Butt AA, Bidwell Goetz M, Leaf D, Oursler KA, Rimland D, Rodriguez Barradas M, Brown S, Gibert C, McGinnis K, Crothers K, Sico J, Crane H, Warner A, Gottlieb S, Gottdiener J, Tracy RP, Budoff M, Watson C, Armah KA, Doebler D, Bryant K, Justice AC. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173:614–622. - PMC - PubMed
-
- Pearce D, Ani C, Espinosa-Silva Y, Clark R, Fatima K, Rahman M, Diebolt E, Ovbiagele B. Comparison of in-hospital mortality from acute myocardial infarction in HIV sero-positive versus sero-negative individuals. Am J Cardiol. 2012;110:1078–1084. - PubMed